Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lumbar Vertebrae | 3 | 2018 | 105 | 0.820 |
Why?
|
| Sacroiliac Joint | 1 | 2021 | 1 | 0.800 |
Why?
|
| Arthrodesis | 1 | 2021 | 10 | 0.790 |
Why?
|
| Patient Positioning | 1 | 2021 | 35 | 0.780 |
Why?
|
| Neurilemmoma | 2 | 2018 | 28 | 0.760 |
Why?
|
| Sacrum | 1 | 2018 | 18 | 0.650 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2018 | 63 | 0.640 |
Why?
|
| Spinal Neoplasms | 1 | 2018 | 32 | 0.640 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2017 | 11 | 0.620 |
Why?
|
| Orthopedic Procedures | 1 | 2018 | 82 | 0.610 |
Why?
|
| Cervical Vertebrae | 1 | 2017 | 65 | 0.600 |
Why?
|
| Spinal Fusion | 4 | 2022 | 71 | 0.570 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2018 | 1616 | 0.560 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2011 | 57 | 0.450 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2010 | 24 | 0.440 |
Why?
|
| Brain Mapping | 2 | 2011 | 250 | 0.410 |
Why?
|
| Middle Aged | 13 | 2022 | 13083 | 0.350 |
Why?
|
| Female | 19 | 2022 | 28474 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 1222 | 0.270 |
Why?
|
| Treatment Outcome | 6 | 2021 | 5612 | 0.240 |
Why?
|
| Male | 15 | 2022 | 27348 | 0.220 |
Why?
|
| Platybasia | 1 | 2022 | 6 | 0.220 |
Why?
|
| Humans | 20 | 2022 | 54397 | 0.220 |
Why?
|
| Carotid Artery Diseases | 1 | 2002 | 38 | 0.210 |
Why?
|
| Epilepsy, Frontal Lobe | 2 | 2002 | 5 | 0.210 |
Why?
|
| Diagnostic Errors | 1 | 2002 | 74 | 0.210 |
Why?
|
| Intracranial Aneurysm | 1 | 2002 | 54 | 0.210 |
Why?
|
| Adult | 13 | 2022 | 14210 | 0.200 |
Why?
|
| Organotechnetium Compounds | 2 | 2011 | 8 | 0.200 |
Why?
|
| Cysteine | 2 | 2011 | 62 | 0.190 |
Why?
|
| Aged | 7 | 2021 | 10061 | 0.180 |
Why?
|
| Epidural Neoplasms | 1 | 2019 | 5 | 0.180 |
Why?
|
| Spinal Cord Compression | 1 | 2019 | 10 | 0.180 |
Why?
|
| Feasibility Studies | 1 | 2021 | 398 | 0.180 |
Why?
|
| Radiopharmaceuticals | 2 | 2011 | 242 | 0.170 |
Why?
|
| Electroencephalography | 4 | 2010 | 357 | 0.170 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2018 | 10 | 0.170 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2018 | 15 | 0.170 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2018 | 23 | 0.170 |
Why?
|
| Patient Care Planning | 1 | 2018 | 79 | 0.160 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 100 | 0.160 |
Why?
|
| Cohort Studies | 2 | 2021 | 1547 | 0.160 |
Why?
|
| Thoracic Vertebrae | 1 | 2018 | 46 | 0.150 |
Why?
|
| Encephalomalacia | 1 | 1997 | 1 | 0.150 |
Why?
|
| Neurosurgical Procedures | 1 | 2018 | 121 | 0.150 |
Why?
|
| Retrospective Studies | 7 | 2022 | 6460 | 0.150 |
Why?
|
| Frontal Lobe | 1 | 1997 | 56 | 0.150 |
Why?
|
| Neurofibromatoses | 1 | 2016 | 6 | 0.140 |
Why?
|
| Spondylolisthesis | 1 | 2016 | 9 | 0.140 |
Why?
|
| Biopsy | 1 | 2018 | 692 | 0.130 |
Why?
|
| Spine | 1 | 2015 | 112 | 0.130 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 126 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2021 | 2606 | 0.120 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 323 | 0.120 |
Why?
|
| Brain | 3 | 2011 | 1392 | 0.120 |
Why?
|
| Young Adult | 4 | 2022 | 4319 | 0.110 |
Why?
|
| Functional Laterality | 2 | 2010 | 99 | 0.110 |
Why?
|
| Adolescent | 6 | 2019 | 6901 | 0.110 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 2011 | 1 | 0.100 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2011 | 5 | 0.100 |
Why?
|
| Intervertebral Disc | 1 | 2011 | 8 | 0.100 |
Why?
|
| Subtraction Technique | 1 | 2010 | 17 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 532 | 0.090 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2009 | 2 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2016 | 1035 | 0.080 |
Why?
|
| Cerebral Hemorrhage | 1 | 2008 | 105 | 0.080 |
Why?
|
| Warfarin | 1 | 2008 | 87 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2008 | 75 | 0.080 |
Why?
|
| Supratentorial Neoplasms | 1 | 2006 | 4 | 0.070 |
Why?
|
| Cerebellopontine Angle | 1 | 2006 | 7 | 0.070 |
Why?
|
| Cerebellar Diseases | 1 | 2006 | 18 | 0.070 |
Why?
|
| Cerebellar Neoplasms | 1 | 2006 | 23 | 0.070 |
Why?
|
| Prognosis | 4 | 2015 | 2126 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2008 | 270 | 0.070 |
Why?
|
| Time Factors | 1 | 2010 | 3210 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2002 | 68 | 0.050 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2002 | 33 | 0.050 |
Why?
|
| Nose | 1 | 2022 | 42 | 0.050 |
Why?
|
| Decompression, Surgical | 1 | 2022 | 52 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 3431 | 0.050 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 22 | 0.040 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 106 | 0.040 |
Why?
|
| Polysomnography | 1 | 1997 | 71 | 0.040 |
Why?
|
| Probability | 1 | 1997 | 177 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2015 | 59 | 0.030 |
Why?
|
| Steroids | 1 | 2015 | 55 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 200 | 0.030 |
Why?
|
| Risk Factors | 2 | 2015 | 3937 | 0.030 |
Why?
|
| Inpatients | 1 | 2015 | 206 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 643 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 766 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 683 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2015 | 712 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1199 | 0.030 |
Why?
|
| Dominance, Cerebral | 1 | 2011 | 28 | 0.030 |
Why?
|
| Smoking | 1 | 2015 | 553 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 177 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 256 | 0.020 |
Why?
|
| Health Surveys | 1 | 2011 | 262 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 430 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2009 | 29 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 514 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2009 | 75 | 0.020 |
Why?
|
| Time | 1 | 2008 | 36 | 0.020 |
Why?
|
| Child | 2 | 2002 | 7368 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1997 | 4158 | 0.020 |
Why?
|
| Mortality | 1 | 2008 | 102 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2008 | 122 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2009 | 184 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 401 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2009 | 212 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1026 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 1084 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 363 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 107 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 736 | 0.020 |
Why?
|
| Neoplasms | 1 | 1996 | 1322 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2019 | 3050 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2008 | 1362 | 0.010 |
Why?
|
| Stroke | 1 | 2008 | 526 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 2390 | 0.010 |
Why?
|
| Scalp | 1 | 2002 | 53 | 0.010 |
Why?
|
| Forecasting | 1 | 2002 | 161 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 1045 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 1996 | 134 | 0.010 |
Why?
|
| Emotions | 1 | 1996 | 170 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 1996 | 302 | 0.010 |
Why?
|
| Melanoma | 1 | 1996 | 313 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1996 | 1249 | 0.000 |
Why?
|